host picture
Bookmark and Share

How a U.S. Supreme Court ruling will affect gene medical research

A private company tried to patent the faulty gene, BRCA, linked with higher rates of breast and ovarian cancer. We speak with a health law professor about what the court ruling means here.

Download Flash Player to view this content.